ODVNX
Price
$37.34
Change
-$0.00 (-0.00%)
Updated
Sep 6 closing price
VEMRX
Price
$91.73
Change
-$0.00 (-0.00%)
Updated
Sep 6 closing price
Ad is loading...

ODVNX vs VEMRX

Header iconODVNX vs VEMRX Comparison
Open Charts ODVNX vs VEMRXBanner chart's image
Invesco Developing Markets R
Price$37.34
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Emerging Mkts Stock Idx InsPlus
Price$91.73
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
ODVNX vs VEMRX Comparison Chart
Loading...
VS
ODVNX vs. VEMRX commentary
Sep 16, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ODVNX is a StrongSell and VEMRX is a Buy.

FUNDAMENTALS
Fundamentals
VEMRX has more cash in the bank: 108B vs. ODVNX (19.3B). VEMRX pays higher dividends than ODVNX: VEMRX (3.48) vs ODVNX (0.29). ODVNX was incepted earlier than VEMRX: ODVNX (24 years) vs VEMRX (14 years). ODVNX is a more actively managed with annual turnover of: 25.00 vs. VEMRX (5.00). ODVNX has a lower initial minimum investment than VEMRX: ODVNX (1000) vs VEMRX (100000000). VEMRX annual gain was more profitable for investors over the last year : 11.91 vs. ODVNX (4.24). VEMRX return over 5 years is better than : 16.35 vs. ODVNX (-8.01).
ODVNXVEMRXODVNX / VEMRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years14 years-
Gain YTD1.5728.59718%
Front LoadN/AN/A-
Min. Initial Investment10001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets19.3B108B18%
Annual Yield % from dividends0.293.488%
Returns for 1 year4.2411.9136%
Returns for 3 years-26.24-8.60305%
Returns for 5 years-8.0116.35-49%
Returns for 10 years-1.7318.94-9%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
METC10.400.33
+3.28%
Ramaco Resources
CE123.143.26
+2.72%
Celanese Corp
AYTU2.580.06
+2.38%
Aytu BioPharma
FOLD11.300.02
+0.18%
Amicus Therapeutics
ALIM5.54-0.01
-0.18%
Alimera Sciences